HomeAI · summaries
Storia in 2 fonti
Lexitas Pharma Services and Ocusun Enroll First Patient in a Pilot Study for an Upcoming Phase III Clinical Trial Evaluating Investigational Eye Drop for Age-Related Cataract
Lexitas Pharma Services and Ocusun Enroll First Patient in a Pilot Study for an Upcoming Phase III Clinical Trial Evaluating Investigational Eye Drop for Age-Related Cataract
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Lexitas Pharma Services and Ocusun Enroll First Patient in a Pilot Study for an Upcoming Phase III Clinical Trial Evaluating…
Lexitas Pharma Services and Ocusun Enroll First Patient in a Pilot Study for an Upcoming Phase III Clinical Trial Evaluating Investigational Eye Drop for Age-Related Cataract
- ·
healio.com
Eye drop for cataracts to be evaluated in pilot study
ZOC2017217, an eye drop aimed at slowing or reversing the development of cataracts, is undergoing a pilot study ahead of a potential phase 3 trial, according to a press release…